Rapid Micro Biosystems Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -158.0% | -149.9% | -276.7% | -152.9% | -113.1% | -120.6% | -125.8% | -133.6% | -115.5% | -28.8% | -188.2% | -157.7% | -113.9% | |
| 12.7% | 12.5% | 14.4% | 12.5% | 11.3% | 10.6% | 11.8% | 11.2% | 10.3% | 7.0% | 8.8% | 8.4% | 8.5% | |
| 20.4% | 16.1% | 19.3% | 17.7% | 12.2% | 8.4% | 14.5% | 16.8% | 14.6% | 5.6% | 15.3% | 16.4% | 12.3% | |
| 30.9% | 1.2% | -71.1% | 7.9% | 10.1% | -25.2% | -4.0% | -7.0% | -0.4% | 61.1% | -40.3% | -27.8% | 4.0% | |
| 7.4% | 6.6% | 10.4% | 6.9% | 2.9% | 1.2% | 4.4% | 5.0% | 0.9% | 0.8% | 4.9% | 2.8% | 2.2% | |
| 77.6% | 157.9% | 240.9% | 375.0% | -86.0% | 59.2% | 148.2% | 128.7% | -122.3% | 34.5% | 107.4% | 52.4% | 20.2% | |
| – | 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | 3.0% | – | 0.8% | – | 1.2% | – | 2.1% | – | – | 1.7% | – | |
| – | – | – | – | -0.1% | -0.1% | -0.1% | -0.1% | 255.1% | -0.1% | -0.1% | -0.1% | 56.8% | |
| 0.8% | -0.2% | 2.8% | -0.2% | 0.8% | -0.1% | 5.3% | -4.1% | 245.6% | 3.9% | 3.1% | 116.1% | 83.3% | |
| -79.6% | 7.9% | -33.0% | 221.9% | -198.3% | -61.5% | 27.7% | -7.9% | 7.8% | 9.6% | -77.7% | 10.8% | -10.4% | |
| -165.4% | -156.5% | -287.1% | -159.8% | -116.0% | -121.8% | -130.2% | -138.6% | -116.4% | -29.6% | -193.1% | -154.9% | -114.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.